Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Neutral
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
FOXO Technologies Inc. (FOXO)
Services-commercial Physical & Biological Research
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging.
729 WASHINGTON AVE. N, SUITE 600
MINNEAPOLIS, MN
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
09/19/2022
Market Cap
1,748,431
Shares Outstanding
6,400,000
Weighted SO
6,396,832
Total Employees
N/A
Upcoming Earnings
N/A
Beta
2.0170
Last Div
0.0000
Range
0.13-2.61
Chg
0.0030
Avg Vol
1995482
Mkt Cap
1748431
Exch
AMEX
Country
US
Phone
612-562-9447
DCF Diff
N/A
DCF
0.0000
Div Yield
0.0000
P/S
8.4875
EV Multiple
-0.4900
P/FV
-0.0925
Div Yield %
0.0000
P/E
-0.0680
PEG
-0.0007
Payout
-0.1986
Current Ratio
0.0153
Quick Ratio
0.0153
Cash Ratio
0.0002
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
13004.4286
CCC
-13004.4286
Gross Margin
0.3204
Op Margin
-77.5485
Pretax Margin
-98.6214
Net Margin
-98.6214
Eff Tax Rate
0.2567
ROA
-6.7856
ROE
1.7228
ROCE
1.1347
NI/EBT
1.0000
EBT/EBIT
1.2717
EBIT/Rev
-77.5485
Debt Ratio
1.6570
D/E
-0.3321
LT Debt/Cap
-0.0346
Total Debt/Cap
-0.4973
Int Coverage
-18.9277
CF/Debt
-0.3163
Equity Multi
-0.2004
Rec Turnover
0.0000
Pay Turnover
0.0281
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0688
OCF/Share
-0.1759
FCF/Share
-0.4139
Cash/Share
0.0003
OCF/Sales
-7.6165
FCF/OCF
2.3525
CF Coverage
-0.3163
ST Coverage
-0.3517
CapEx Coverage
-0.7394
Div&CapEx Cov
-0.2549
P/BV
-0.0925
P/B
-0.0925
P/S
8.4875
P/E
-0.0680
P/FCF
-0.4737
P/OCF
-0.8810
P/CF
-0.8810
PEG
-0.0007
P/S
8.4875
EV Multiple
-0.4900
P/FV
-0.0925
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0.00 %)
3.90M Shares Sold (100.00%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2021 | 2023 | 2024 | 2024 | 1970 | 1970 | 1970 | |
---|---|---|---|---|---|---|---|
Revenue | 27.00K | ▲ 418.00K | ▼ 169.00K | ▼ 15.00K | ▼ | ||
Cost Of Revenue | 0.00 | ▲ 344.00K | ▼ 62.00K | ▼ 8.00K | ▼ | ||
Gross Profit | 27.00K | ▲ 74.00K | ▲ 107.00K | ▼ 7.00K | ▼ | ||
Gross Profit Ratio | 1.00 | ▼ 0.18 | ▲ 0.63 | ▼ 0.47 | ▼ | ||
Research And Development Expenses | 558.00K | ▲ 887.00K | ▼ -24.00K | ▲ 165.00K | ▼ | ||
General And Administrative Expenses | 0.00 | ▲ 10.09M | ▼ 2.97M | ▼ 0.00 | |||
Selling And Marketing Expenses | 0.00 | ▲ 9.96M | ▼ -12.09M | ▲ 0.00 | |||
Selling General And Administrative Expenses | 2.63M | ▲ 20.05M | ▼ 4.35M | ▼ 988.00K | ▼ | ||
Other Expenses | 2.98M | ▼ -21.28M | ▲ -3.79M | ▲ -1.22M | ▼ | ||
Operating Expenses | 3.19M | ▲ 18.21M | ▼ 3.79M | ▼ 1.22M | ▼ | ||
Cost And Expenses | 3.19M | ▲ 18.55M | ▼ -3.79M | ▲ -1.22M | ▼ | ||
Interest Income | 0.00 | ▲ 190.00K | ▼ 0.00 | 0.00 | |||
Interest Expense | 0.00 | ▲ 190.00K | ▲ 199.00K | ▲ 301.00K | ▼ | ||
Depreciation And Amortization | 27.00K | ▲ 1.33M | ▼ 28.00K | ▲ 260.00K | ▼ | ||
Ebitda | 21.79M | ▼ -19.53M | ▲ -4.28M | ▲ -918.00K | ▼ | ||
Ebitda Ratio | 100.00 | ▼ -46.73 | ▲ -25.34 | ▼ -61.20 | ▼ | ||
Operating Income | -3.16M | ▼ -20.86M | ▲ -3.68M | ▲ -1.18M | ▼ | ||
Operating Income Ratio | -117.15 | ▲ -49.91 | ▲ -21.80 | ▼ -78.60 | ▼ | ||
Total Other Income Expenses Net | 2.58M | ▼ 2.54M | ▼ -3.86M | ▲ -1.50M | ▼ | ||
Income Before Tax | -874.00K | ▼ -18.32M | ▲ -3.86M | ▲ -1.50M | ▼ | ||
Income Before Tax Ratio | -32.37 | ▼ -43.83 | ▲ -22.83 | ▼ -100.00 | ▼ | ||
Income Tax Expense | 25.21M | ▼ 0.00 | ▼ -4.31M | ▲ -1.44M | ▼ | ||
Net Income | -874.00K | ▼ -18.32M | ▲ -3.86M | ▲ -1.50M | ▼ | ||
Net Income Ratio | -32.37 | ▼ -43.83 | ▲ -22.83 | ▼ -100.00 | ▼ | ||
Eps | 0.44 | ▼ -6.66 | ▲ -0.50 | ▲ -0.17 | ▼ | ||
Eps Diluted | 0.04 | ▼ -6.66 | ▲ -0.50 | ▲ -0.17 | ▼ | ||
Weighted Average Shs Out | 2.58M | ▲ 2.75M | ▲ 7.65M | ▲ 8.92M | ▼ | ||
Weighted Average Shs Out Dil | 2.58M | ▲ 2.75M | ▲ 7.65M | ▲ 8.92M | ▼ |